Skip to content

Pracchana karma and aragwadhadi taila application in the treatment of shwitra

Clinical evaluation of pracchana karma and aragwadhadi taila application in the management of shwitra - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/10/095788
Enrollment
30
Registered
2025-10-09
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L80- Vitiligo

Interventions

None listed

Sponsors

Dr Hemant singh chauhan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. patient with single or multiple patches 2. maximum number of patches 6 3. maximum size in diameter 8cm

Exclusion criteria

Exclusion criteria: 1. patient below 20 years and above 60years of age 2. patients contraindicated for raktmokshan 3. pregnant and lactating mother 4. generalised vitiligo 5. patches due to burning, chemical explosion etc. and located at region of guhya (genital region), panitala (foot soles and hand soles), oshtha (lips), sarvang(whole body), patches with rakta roma (reddish hair) and samsakta (coalescent) 6. vitiligo associated with other disease like hypothyroidism , anemia ,diabetes, hypertension, tuberculosis, RA, SLE etc. 7. HIV, HCV, VDRL, HBSAG POSITIVE

Design outcomes

Primary

MeasureTime frame
To study the effect of Pracchana karma and Aragwadhadi taila on colour of the skin , itching and dryness in vitiligoTimepoint: Assessment will be done on 7th , 14th 21st 28th 35th 45th day

Secondary

MeasureTime frame
Quality of life & cosmetic effectsTimepoint: Assessment of the symptoms on 7th 14th 21st 28th 35th & 45th day

Countries

India

Contacts

Public ContactDr Elizabeth p john

vaidya yagya dutt sharma ayurved mahavidyalaya khurja bulandshahr

elizajhn@yahoo.co.in9448345918

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026